Associations of antiplatelet therapy and beta blockade with patient outcomes in atherosclerotic renovascular disease

James Ritchie, Darren Green, Helen V Alderson, Constantina Chrysochou, Diana Vassallo, Smeeta Sinha, Philip A Kalra

Research output: Contribution to journalArticlepeer-review


Randomized trials have shown a neutral effect of percutaneous revascularization compared with optimal medical therapy in patients with atherosclerotic renovascular disease (ARVD). However, there are few data to define what constitutes optimal medical therapy. We present a retrospective analysis of 529 ARVD patients. Separate analyses were performed comparing outcomes in patients prescribed/not prescribed beta blocker and antiplatelet agents. Analyses were adjusted for effects of baseline covariates on probability of treatment and on clinical outcome. Over a median follow-up period of 3.8 years, antiplatelet therapy was associated with a reduced risk for death (relative risk, 0.52 [95% confidence interval {CI}: 0.31-0.89]; P = .02). Beta blocker therapy was associated with a reduced for death (relative risk, 0.45 [95% CI: 0.21-0.97]; P = .04) and nonfatal cardiovascular events (relative risk, 0.74 [95% CI: 0.60-0.90]; P = .003). Although limited by small patient numbers, this study suggests that in ARVD, treatment with antiplatelet therapy and beta blockade may associate with a prognostic benefit.

Original languageEnglish
Pages (from-to)149-158.e3
JournalJournal of the American Society of Hypertension : JASH
Issue number2
Publication statusPublished - Feb 2016


  • Adrenergic beta-Antagonists
  • Aged
  • Aged, 80 and over
  • Angioplasty
  • Angiotensin Receptor Antagonists
  • Atherosclerosis
  • Cohort Studies
  • Female
  • Follow-Up Studies
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Hypertension, Renovascular
  • Male
  • Middle Aged
  • Platelet Aggregation Inhibitors
  • Prognosis
  • Randomized Controlled Trials as Topic
  • Renal Artery
  • Renal Artery Obstruction
  • Retrospective Studies
  • Stents
  • Treatment Outcome
  • Journal Article


Dive into the research topics of 'Associations of antiplatelet therapy and beta blockade with patient outcomes in atherosclerotic renovascular disease'. Together they form a unique fingerprint.

Cite this